The S&P 500 is due for a dip because the forces that drive profit are weak despite economic improvement elsewhere, David Bianco tells CNBC.» Read More
Mad Money host Jim Cramer was hoping the markets would move on from worrying about Greece, in discussing stocks that showed signs of life in Tuesday's trading.
Jim Cramer won't even make a call on this stock during the lightning round.
How to trade Disney and Wal-Mart in the second half of the year, which kicks off tomorrow, with the "Fast Money" crew.
High-end retailers Kate Spade, Coach and Michael Kors ended the day lower.
The "Fast Money" traders discuss ways to play Apple and Twitter on the last day of the first half.
The State Department plans to release Hillary Clinton's emails tonight, and a "no gays allowed" sign was seen on a Tennessee store, reports CNBC's Sue Herera.
This has been a year characterized by difficulty, explains Dan Greenhaus, BTIG. "Fast Money" trader Guy Adami, and CNBC's Jon Fortt, provide perspective.
CNBC's Jackie DeAngelis discusses the day's activity in the commodities markets.
CNBC's Bob Pisani and Bill Griffeth discusses market activity so far this year.
California Governor Jerry Brown has signed a vaccination bill, and a former BP engineer is entitled to a new trial, reports CNBC's Sue Herera.
Dissecting the day's Greek headlines and their impact on markets, with David Lebovitz, JPMorgan; Alan Valdes, DME Securities; and CNBC's Rick Santelli.
Charlie Bobrinksoy, Ariel Investments, provides perspective on current market conditions.
Discussing the debt threats in Puerto Rico, with Del. Pedro Pierluisi, (D) Puerto Rico, who proposes access to Chapter 9.
Will Apple Music be successful enough to stand up against competition? CNBC contributor Natali Morris, and Jeff Price, Audiam CEO, discuss the new service. The trade on Apple, with Brian White, Cantor Fitzgerald.
The latest on Greece's proposal to creditors, with CNBC's Michelle Caruso-Cabrera, who also speaks with a business owner.
CNBC's Jackie DeAngelis tracks oil action into the close.
The latest on Lynn Tilton's fight to block SEC fraud case, with CNBC's Mandy Drury.
Celgene has invested $1 billion in Juno Therapeutics. Tony Butler, Guggenheim Partners managing director, looks at the move in the Juno's stock.
CNBC's Bob Pisani looks at recent market action on news out of Greece.
Janus portfolio manager Bill Gross discusses when the Fed may raise interest rates and the impact it will have on the market.